Factors related to underuse of surveillance mammography among breast cancer survivors

Journal of Clinical Oncology

Volumn 24, Issue 1, 2006, Pages 85-94

  Keating, Nancy L ^a   Landrum, Mary Beth ^a   Guadagnoli, Edward ^a   Winer, Eric P ^a   Ayanian, John Z ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; BREAST CANCER; BREAST SURGERY; CANCER STAGING; CANCER SURVIVOR; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEALTH CARE PERSONNEL; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MARRIAGE; MEDICARE; PRIORITY JOURNAL; RACE DIFFERENCE; BREAST TUMOR; CANCER REGISTRY; COHORT ANALYSIS; RADIOGRAPHY; SURVIVOR;

AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; COHORT STUDIES; FEMALE; HUMANS; MAMMOGRAPHY; SEER PROGRAM; SURVIVORS;

EID: 33644835822     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.02.4174     Document Type: Article

References (64)

1. American Society of Clinical Oncology: Recommended breast cancer surveillance guidelines. J Clin Oncol 15:2149-2156, 1997
2. Smith TJ, Davidson NE, Schapira DV, et al: American Society of Clinical Oncology 1998 update of recommended breast cancer surveillance guidelines. J Clin Oncol 17:1080-1082, 1999
3. National Comprehensive Cancer Network: Update of the NCCN guidelines for treatment of breast cancer. Oncology (Williston Park) 11:199-220, 1997
4. National Comprehensive Cancer Network: NCCN Practice Guidelines in Oncology, v. 1.2005. http://www.nccn.org/professionals/physician_gls/ PDF/breast.pdf
5. Hillner BE, McDonald MK, Penberthy L, et al: Measuring standards of care for early breast cancer in an insured population. J Clin Oncol 15:1401-1408, 1997
6. Andersen MR, Urban N: The use of mammography by survivors of breast cancer. Am J Public Health 88:1713-1714, 1998
7. Schapira MM, McAuliffe TL, Nattinger AB: Underutilization of mammography in older breast cancer survivors. Med Care 38:281-289, 2000
8. Lash TL, Silliman RA: Medical surveillance after breast cancer diagnosis. Med Care 39:945-955, 2001
9. Geller BM, Kerlikowske K, Carney PA, et al: Mammography surveillance following breast cancer. Breast Cancer Res Treat 81:107-115, 2003
10. Blustein J: Medicare coverage, supplemental insurance, and the use of mammography by older women. N Engl J Med 332:1138-1143, 1995
11. Burns RB, McCarthy EP, Freund KM, et al: Black women receive less mammography even with similar use of primary care. Ann Intern Med 125: 173-182, 1996
12. Burns RB, McCarthy EP, Freund KM, et al: Variability in mammography use among older women. J Am Geriatr Soc 44:922-926, 1996
13. Blackman DK, Bennett EM, Miller DS: Trends in self-reported use of mammograms (1989-1997) and Papanicolaou tests (1991-1997) - Behavioral Risk Factor Surveillance System. MMWR CDC Surveill Summ 48:1-22, 1999
14. Ayanian JZ, Weissman JS, Schneider EC, et al: Unmet health needs of uninsured adults in the United States. JAMA 284:2061-2069, 2000
15. NCI Breast Cancer Screening Consortium: Screening mammography: A missed clinical opportunity? Results of the NCI Breast Cancer Screening Consortium and National Health Interview Survey Studies. JAMA 264:54-58, 1990
16. Potosky AL, Riley GF, Lubitz JD, et al: Potential for cancer related health services research using a linked Medicare-tumor registry database. Med Care 31:732-748, 1993
17. Ries LA, Wingo PA, Miller DS, et al: The annual report to the nation on the status of cancer, 1973-1997, with a special section on colorectal cancer. Cancer 88:2398-2424, 2000
18. Keating NL, Landrum MB, Meara E, et al: Do increases in managed care market share of managed are influence quality of cancer care in the fee-for-service sector? J Natl Cancer Inst 97:257-264, 2005
19. Edelman MJ, Meyers FJ, Siegel D: The utility of follow-up testing after curative cancer therapy: A critical review and economic analysis. J Gen Intern Med 12:318-331, 1997
20. Baldwin LM, Adamache W, Klabunde C, et al: Linking physician characteristics and Medicare claims data: Issues in data availability, quality, and measurement. Med Care 40:IV-82-IV-95, 2002
21. Bach PB, Guadagnoli E, Schrag D, et al: Patient demographic and socioeconomic characteristics in the SEER-Medicare database applications and limitations. Med Care 40:IV-19-IV-25, 2002
22. American Joint Committee on Cancer: AJCC Cancer Staging Manual (ed 5). New York, NY, Springer Verlag, 1997
23. Keating NL, Landrum MB, Ayanian JZ, et al: Consultation with a medical oncologist before surgery and type of surgery among elderly women with early-stage breast cancer. J Clin Oncol 21:4532-4539, 2003
24. Cooper GS, Virnig B, Klabunde CN, et al: Use of SEER-Medicare data for measuring cancer surgery. Med Care 40IV-43-IV-48, 2002
25. Du X, Freeman JL, Goodwin JS: Information on radiation treatment in patients with breast cancer: The advantages of the linked Medicare and SEER data. J Clin Epidemiol 52:463-470, 1999
26. Ellis RP, Pope GC, Iezzoni LI, et al: Diagnosis-based risk adjustment for Medicare capitation payments. Health Care Financ Rev 17:101-128, 1996
27. Charlson ME, Pompei P, Ales KL, et al: A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 40:373-383, 1987
28. Ash AS, Posner MA, Speckman J, et al: Using claims data to examine mortality trends following hospitalizatipn for heart attack in Medicare. Health Serv Res 38:1253-1262, 2003
29. Zeger SL, Liang K: Longitudinal data analysis for discrete and continuous outcomes. Biometrics 42:121-130, 1986
30. Deyo RA, Cherkin DC, Ciol MA: Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 45:613-619, 1992
31. Li CI, Malone KE, Daling JR: Differences in breast cancer stage, treatment, and survival by race and ethnicity. Arch Intern Med 163:49-56, 2003
32. Eley JW, Hill HA, Chen VW, et al: Racial differences in survival from breast cancer: Results of the National Cancer Institute Black/White Cancer Survival Study. JAMA 272:947-954, 1994
33. Roetzheim RG, Pal N, Tennant C, et al: Effects of health insurance and race on early detection of cancer. J Natl Cancer Inst 91:1409-1415, 1999
34. Mandelblatt JS, Kerner JF, Hadley J, et al: Variations in breast carcinoma treatment in older Medicare beneficiaries: Is it black or white. Cancer 95:1401-1414, 2002
35. McWhorter WP, Mayer WJ: Black/white differences in type of initial breast cancer treatment and implications for survival. Am J Public Health 77:1515-1517, 1987
36. Bradley CJ, Given CW, Roberts C: Race, socioeconomic status, and breast cancer treatment and survival. J Natl Cancer Inst 94:490-496, 2002
37. Elmore JG, Nakano CY, Linden HM, et al: Racial inequities in the timing of breast cancer detection, diagnosis, and initiation of treatment. Med Care 43:141-148, 2005
38. Gwyn K, Bondy ML, Cohen DS, et al: Racial differences in diagnosis, treatment, and clinical delays in a population-based study of patients with newly diagnesed breast carcinoma. Cancer 100: 1595-1604, 2004
39. Ayanian JZ, Kohler BA, Abe T, et al: The relation between health insurance coverage and clinical outcomes among women with breast cancer. N Engl J Med 329:326-331, 1993
40. Ayanian JZ, Guadagnoli E: Variations in breast cancer treatment by patient and provider characteristics. Breast Cancer Res Treat 40:65-74, 1996
41. Cross CK, Harris J, Recht A: Race, socioeconomic status, and breast carcinoma in the U.S: What have we learned from clinical studies. Cancer 95: 1988-1999, 2002
42. Roetzheim RG, Gonzalez EC, Ferrante JM, et al: Effects of health insurance and race on breast carcinoma treatments and outcomes. Cancer 89: 2202-2213, 2000
43. Krieger N: Overcoming the absence of socioeconomic data in medical records: Validation and application of a census-based methodology. Am J Public Health 82:703-710, 1992
44. Geronimus A, Bound J, Wagner E: On the validity of using census geocode data to proxy individual socioeconomic characteristics. J Am Stat Assoc 91:529-537, 1996
45. Liberati A, Patterson WB, Biener L, et al: Determinants of physicians' preferences for alternative treatments in women with early breast cancer. Tumori 73:601-609, 1987
46. Deber RB, Thompson GG: Who still prefers aggressive surgery for breast cancer? Implications for the clinical applications of clinical trials. Arch Intern Med 147:1543-1547, 1987
47. Keating NL, Weeks JC, Landrum MB, et al: Discussion of treatment options for early-stage breast cancer: Effect of provider specialty on type of surgery and satisfaction. Med Care 39:681-691, 2001
48. Earle CC, Neumann PJ, Gelber RD, et al: Impact of referral patterns on the use of chemotherapy for lung cancer. J Clin Oncol 20:1786-1792, 2002
49. Keating NL, Landrum MB, Ayanian JZ, et al: The association of ambulatory care with breast cancer stage at diagnosis among Medicare beneficiaries. J Gen Intern Med 20:38-44, 2005
50. Roetzheim RG, Pal N, Gonzalez EC, et al: The effects of physician supply on the early detection of colorectal cancer. J Fam Pract 48:850-858, 1999
51. Earle CC, Burstein HJ, Winer EP, et al: Quality of non-breast cancer health maintenance among elderly breast cancer survivors. J Clin Oncol 21: 1447-1451, 2003
52. Siminoff LA, Zhang A, Saunders Sturm CM, et al: Referral of breast cancer patients to medical oncologists after initial surgical management. Med Care 38:696-704, 2000
53. Worster A, Wood ML, McWhinney IR, et al: Who provides follow-up care for patients with early breast cancer? Can Fam Physician 41:1314-1320, 1995
54. Satariano WA, Ragland DR: The effect of comorbidity on 3-year survival of women with primary breast cancer. Ann Intern Med 120:104-110, 1994
55. Senofsky GM, Wanebo HJ, Wilhelm MC, et al: Has monitoring of the contralateral breast improved the prognosis in patients treated for primary breast cancer? Cancer 57:597-602, 1986
56. Mellink WA, Holland R, Hendriks JH, et al: The contribution of routine follow-up mammography to an early detection of asynchronous contralateral breast cancer. Cancer 67:1844-1848, 1991
57. Orel SG, Fowble BL, Solin U, et al: Breast cancer recurrence after lumpectomy and radiation therapy for early-stage disease: Prognostic significance of detection method. Radiology 188:189-194, 1993
58. Muttarak M, Pojchamarnwiputh S, Padungchaichote W, et al: Evaluation of the contralateral breast in patients with ipsilateral breast carcinoma: The role of mammography. Singapore Med J 43:229-233, 2002
59. National Center for Health Statistics: Health, United States, 2004, with Chartbook on Trends in the Health of Americans. Hyattsville, MD, National Center for Health Statistics, 2004
60. Ries LAG, Eisner MP, Kosary CL, et al: SEER Cancer Statistics Review, 1973-1999. http://seer .cancer.gov/csr/1973_1999/
61. Warren JL, Klabunde CN, Schrag D, et al: Overview of the SEER-Medicare data: Content, research applications, and generalizability to the United States elderly population. Med Care 40:IV-3-IV-18, 2002
62. Nattinger AB, McAuliffe TL, Schapira MM: Generalizability of the surveillance, epidemiology, and end results registry population: Factors relevant to epidemiologic and health care research. J Clin Epidemiol 50:939-945, 1997
63. Silliman RA, Guadagnoli E, Weitberg AB, et al: Age as a predictor of diagnostic and initial treatment intensity in newly diagnosed breast cancer patients. J Gerontol 44:M46-M50, 1989
64. Silliman RA, Troyan SL, Guadagnoli E, et al: The impact of age, marital status, and physician-patient interactions on the care of older women with breast carcinoma. Cancer 80:1326-1334, 1997